NL6915958A - - Google Patents

Info

Publication number
NL6915958A
NL6915958A NL6915958A NL6915958A NL6915958A NL 6915958 A NL6915958 A NL 6915958A NL 6915958 A NL6915958 A NL 6915958A NL 6915958 A NL6915958 A NL 6915958A NL 6915958 A NL6915958 A NL 6915958A
Authority
NL
Netherlands
Application number
NL6915958A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of NL6915958A publication Critical patent/NL6915958A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/10Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D241/14Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D241/24Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D241/26Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with nitrogen atoms directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
NL6915958A 1968-11-20 1969-10-22 NL6915958A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US77747968A 1968-11-20 1968-11-20

Publications (1)

Publication Number Publication Date
NL6915958A true NL6915958A (pt) 1970-05-22

Family

ID=25110373

Family Applications (1)

Application Number Title Priority Date Filing Date
NL6915958A NL6915958A (pt) 1968-11-20 1969-10-22

Country Status (8)

Country Link
US (1) US3549633A (pt)
AT (1) AT291250B (pt)
BR (1) BR6914169D0 (pt)
CH (1) CH518957A (pt)
ES (1) ES373698A1 (pt)
FR (1) FR2070653A1 (pt)
GB (1) GB1242625A (pt)
NL (1) NL6915958A (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4053577A (en) * 1972-02-18 1977-10-11 Tioxide Group Limited Process for the gaseous phase production of metal oxide particles
GR74944B (pt) * 1980-07-02 1984-07-12 Merck & Co Inc
US8614223B2 (en) 2010-11-16 2013-12-24 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as protein deacetylase inhibitors and methods of use thereof
US9403779B2 (en) 2013-10-08 2016-08-02 Acetylon Pharmaceuticals, Inc. Combinations of histone deacetylase inhibitors and either Her2 inhibitors or PI3K inhibitors
EP3055299B1 (en) 2013-10-10 2021-01-06 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as histone deacetylase inhibitors
EP3060217B1 (en) 2013-10-24 2022-06-08 Mayo Foundation for Medical Education and Research Treatment of polycystic diseases with an hdac6 inhibitor
ES2806258T3 (es) 2013-12-03 2021-02-17 Acetylon Pharmaceuticals Inc Combinaciones de inhibidores de histona desacetilasa y fármacos inmunomoduladores
US9464073B2 (en) 2014-02-26 2016-10-11 Acetylon Pharmaceuticals, Inc. Pyrimidine hydroxy amide compounds as HDAC6 selective inhibitors
EA201790142A1 (ru) 2014-07-07 2017-07-31 Эситайлон Фармасьютикалз, Инк. Лечение лейкоза ингибиторами гистондеацетилазы
CN107438436A (zh) 2014-12-05 2017-12-05 摩德纳和雷焦艾米利亚大学 用于治疗淋巴瘤的组蛋白脱乙酰酶抑制剂和苯达莫司汀的组合
US10272084B2 (en) 2015-06-01 2019-04-30 Regenacy Pharmaceuticals, Llc Histone deacetylase 6 selective inhibitors for the treatment of cisplatin-induced peripheral neuropathy
JP2019515909A (ja) 2016-04-19 2019-06-13 アセチロン ファーマシューティカルズ インコーポレイテッドAcetylon Pharmaceuticals,Inc. 慢性リンパ性白血病の治療を目的とするhdac阻害剤単独またはbtk阻害剤との配合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE651729A (pt) * 1962-10-30 1965-02-12
US3361748A (en) * 1965-11-22 1968-01-02 Merck & Co Inc Process for the preparation of pteridinones

Also Published As

Publication number Publication date
BR6914169D0 (pt) 1973-02-22
FR2070653A1 (pt) 1971-09-17
GB1242625A (en) 1971-08-11
AT291250B (de) 1971-07-12
US3549633A (en) 1970-12-22
ES373698A1 (es) 1972-02-01
CH518957A (de) 1972-02-15

Similar Documents

Publication Publication Date Title
AU428130B2 (pt)
AU2374870A (pt)
AU5184069A (pt)
FR2070653A1 (pt)
AU6168869A (pt)
AU6171569A (pt)
AU416157B2 (pt)
AU429879B2 (pt)
AU2581067A (pt)
AU4811568A (pt)
AU421558B1 (pt)
AU3789668A (pt)
AU3224368A (pt)
AU2580267A (pt)
AU4744468A (pt)
AU479894A (pt)
BE642636A (pt)
AU4558658A (pt)
AU463027A (pt)
AU4464266A (pt)
AU479393A (pt)
AU3083868A (pt)
AU4270368A (pt)
AU4224469A (pt)
AU5758767A (pt)